SHEIBAN, Imad
SHEIBAN, Imad
Dip. MEDICINA INTERNA (attivo dal 01/01/1900 al 30/04/2013)
30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter study.
2013-01-01 D'Ascenzo F; Moretti C; Salizzoni S; Bollati M; D'Amico M; Ballocca F; Giordana F; Barbanti M; Ussia GP; Brambilla N; Bedogni F; Biondi Zoccai G; Tamburino C; Gaita F; Sheiban I.
[Left main coronary artery stenosis].
2008-01-01 I. Sheiban;G. G. L Biondi-Zoccai;C. Moretti
[Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery].
2009-01-01 I. Sheiban;G. B. Zoccai;C. Moretti
[Percutaneous transluminal angioplasty: synonymous of quality of life?].
2009-01-01 G. B. Zoccai;M. Lotrionte;I. Sheiban
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
2010-01-01 F. Ribichini;G. Ansalone;A. Bartorelli;F. Beqaraj;A. Berni;S. Colangelo;M. D'Amico;F. D. Rovere;A. Fiscella;G. Gabrielli;C. Indolfi;L. L. Vecchia;P. Loschiavo;G. Marinoni;A. Marzocchi;D. Milazzo;M. Romano;P. Sangiorgio;I. Sheiban;C. Tamburino;B. Tuccillo;R. Villani;B. Cappi;M. J. Lopera Quijada;C. Vassanelli;E. X. E. C. U. T. I. V. E. Trial Investigators
A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions
2009-01-01 Colombo F; Biondi-Zoccai G; Infantino V; Omedé P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Sheiban I
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease
2006-01-01 BIONDI-ZOCCAI GG; LOTRIONTE M; AGOSTONI P; ABBATE A; FUSARO M; BURZOTTA F; TESTA L; SHEIBAN I; SANGIORGI G
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations
2020-01-01 Gallone G.; D'Ascenzo F.; Conrotto F.; Costa F.; Capodanno D.; Muscoli S.; Chieffo A.; Yoichi I.; Pennacchi M.; Quadri G.; Nunez-Gil I.; Bocchino P.P.; Piroli F.; De Filippo O.; Rolfo C.; Wojakowski W.; Trabattoni D.; Huczek Z.; Venuti G.; Montabone A.; Rognoni A.; Parma R.; Figini F.; Mitomo S.; Boccuzzi G.; Mattesini A.; Cerrato E.; Wanha W.; Smolka G.; Cortese B.; Ryan N.; Bo M.; di Mario C.; Varbella F.; Burzotta F.; Sheiban I.; Escaned J.; Helft G.; De Ferrari G.M.
Alterazioni elettrocardiografiche post-TAVI in acuto.
2011-01-01 S. Salizzoni; M. Anselmino; I. Sheiban; C. Fornengo; F. Giordana; M. La Torre; M. D'Amico; S. Marra; M. Rinaldi; F. Gaita.
Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients
2009-01-01 Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I
Antithrombotic strategies following coronary artery stenting in patients on oral anticoagulation for atrial fibrillation
2010-01-01 M. Anselmino; M. Bollati; M. Novara; G. Biondi-Zoccai; I. Sheiban; F. Gaita
Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry.
2013-01-01 D'Ascenzo F;Bollati M;Quadri G;Gonella A;Di Cuia M;De Simone V;Colaci C;Reitano C;Vagnarelli M;Biondi Zoccai G;Moretti C;Sciuto F;Omedè P;Sheiban I;Gaita F
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
2009-01-01 C. Tamburino;M. E. Di Salvo;D. Capodanno;A. Marzocchi;I. Sheiban;M. Margheri;A. Maresta;F. Barlocco;G. Sangiorgi;G. Piovaccari;A. Bartorelli;C. Briguori;D. Ardissino;F. D. Pede;A. Ramondo;L. Inglese;A. S. Petronio;L. Bolognese;A. Benassi;C. Palmieri;A. Patti;S. D. Servi
Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression
2007-01-01 BIONDI-ZOCCAI GG; LOTRIONTE M; AGOSTONI P; VALGIMIGLI M; ABBATE A; SANGIORGI G; MORETTI C; SHEIBAN I.
Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn?
2009-01-01 I. Sheiban;V. Infantino;M. Bollati
Cateterismo cardiaco transettale
2008-01-01 M. Anselmino; G. Biondi-Zoccai; I. Sheiban.
Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary interventions
2008-01-01 Delcré S; Anselmino M; Moretti C; Biondi-Zoccai G; Sheiban I
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
2010-01-01 M. Anselmino;C. Moretti;L. Ravera;I. Sheiban
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
2020-01-01 Iannaccone M.; Barbero U.; De Benedictis M.; Imori Y.; Quadri G.; Trabattoni D.; Ryan N.; Venuti G.; Montabone A.; Wojakowski W.; Rognoni A.; Helft G.; Parma R.; De Luca L.; Autelli M.; Boccuzzi G.; Mattesini A.; Templin C.; Cerrato E.; Wanha W.; Smolka G.; Huczek Z.; Tomassini F.; Cortese B.; Capodanno D.; Chieffo A.; Nunez-Gil I.; Gili S.; Bassignana A.; di Mario C.; Doronzo B.; Omede P.; D'Amico M.; Tedeschi D.; Varbella F.; Luscher T.; Sheiban I.; Escaned J.; Rinaldi M.; D'Ascenzo F.
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
2009-01-01 C. Tamburino;M. E. Di Salvo;D. Capodanno;T. Palmerini;I. Sheiban;M. Margheri;G. Vecchi;G. Sangiorgi;G. Piovaccari;A. Bartorelli;C. Briguori;D. Ardissino;F. D. Pede;A. Ramondo;L. Inglese;A. S. Petronio;L. Bolognese;A. Benassi;C. Palmieri;V. Filippone;S. D. Servi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter study. | 2013 | D'Ascenzo F; Moretti C; Salizzoni S; Bollati M; D'Amico M; Ballocca F; Giordana F; Barbanti M; Ussia GP; Brambilla N; Bedogni F; Biondi Zoccai G; Tamburino C; Gaita F; Sheiban I. | |
| [Left main coronary artery stenosis]. | 2008 | I. Sheiban;G. G. L Biondi-Zoccai;C. Moretti | |
| [Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery]. | 2009 | I. Sheiban;G. B. Zoccai;C. Moretti | |
| [Percutaneous transluminal angioplasty: synonymous of quality of life?]. | 2009 | G. B. Zoccai;M. Lotrionte;I. Sheiban | |
| A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. | 2010 | F. Ribichini;G. Ansalone;A. Bartorelli;F. Beqaraj;A. Berni;S. Colangelo;M. D'Amico;F. D. Rovere;A. Fiscella;G. Gabrielli;C. Indolfi;L. L. Vecchia;P. Loschiavo;G. Marinoni;A. Marzocchi;D. Milazzo;M. Romano;P. Sangiorgio;I. Sheiban;C. Tamburino;B. Tuccillo;R. Villani;B. Cappi;M. J. Lopera Quijada;C. Vassanelli;E. X. E. C. U. T. I. V. E. Trial Investigators | |
| A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions | 2009 | Colombo F; Biondi-Zoccai G; Infantino V; Omedé P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Sheiban I | |
| A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease | 2006 | BIONDI-ZOCCAI GG; LOTRIONTE M; AGOSTONI P; ABBATE A; FUSARO M; BURZOTTA F; TESTA L; SHEIBAN I; SANGIORGI G | |
| Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations | 2020 | Gallone G.; D'Ascenzo F.; Conrotto F.; Costa F.; Capodanno D.; Muscoli S.; Chieffo A.; Yoichi I.; Pennacchi M.; Quadri G.; Nunez-Gil I.; Bocchino P.P.; Piroli F.; De Filippo O.; Rolfo C.; Wojakowski W.; Trabattoni D.; Huczek Z.; Venuti G.; Montabone A.; Rognoni A.; Parma R.; Figini F.; Mitomo S.; Boccuzzi G.; Mattesini A.; Cerrato E.; Wanha W.; Smolka G.; Cortese B.; Ryan N.; Bo M.; di Mario C.; Varbella F.; Burzotta F.; Sheiban I.; Escaned J.; Helft G.; De Ferrari G.M. | |
| Alterazioni elettrocardiografiche post-TAVI in acuto. | 2011 | S. Salizzoni; M. Anselmino; I. Sheiban; C. Fornengo; F. Giordana; M. La Torre; M. D'Amico; S. Marra; M. Rinaldi; F. Gaita. | |
| Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients | 2009 | Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I | |
| Antithrombotic strategies following coronary artery stenting in patients on oral anticoagulation for atrial fibrillation | 2010 | M. Anselmino; M. Bollati; M. Novara; G. Biondi-Zoccai; I. Sheiban; F. Gaita | |
| Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry. | 2013 | D'Ascenzo F;Bollati M;Quadri G;Gonella A;Di Cuia M;De Simone V;Colaci C;Reitano C;Vagnarelli M;Biondi Zoccai G;Moretti C;Sciuto F;Omedè P;Sheiban I;Gaita F | |
| Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. | 2009 | C. Tamburino;M. E. Di Salvo;D. Capodanno;A. Marzocchi;I. Sheiban;M. Margheri;A. Maresta;F. Barlocco;G. Sangiorgi;G. Piovaccari;A. Bartorelli;C. Briguori;D. Ardissino;F. D. Pede;A. Ramondo;L. Inglese;A. S. Petronio;L. Bolognese;A. Benassi;C. Palmieri;A. Patti;S. D. Servi | |
| Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression | 2007 | BIONDI-ZOCCAI GG; LOTRIONTE M; AGOSTONI P; VALGIMIGLI M; ABBATE A; SANGIORGI G; MORETTI C; SHEIBAN I. | |
| Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn? | 2009 | I. Sheiban;V. Infantino;M. Bollati | |
| Cateterismo cardiaco transettale | 2008 | M. Anselmino; G. Biondi-Zoccai; I. Sheiban. | |
| Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary interventions | 2008 | Delcré S; Anselmino M; Moretti C; Biondi-Zoccai G; Sheiban I | |
| Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting. | 2010 | M. Anselmino;C. Moretti;L. Ravera;I. Sheiban | |
| Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) | 2020 | Iannaccone M.; Barbero U.; De Benedictis M.; Imori Y.; Quadri G.; Trabattoni D.; Ryan N.; Venuti G.; Montabone A.; Wojakowski W.; Rognoni A.; Helft G.; Parma R.; De Luca L.; Autelli M.; Boccuzzi G.; Mattesini A.; Templin C.; Cerrato E.; Wanha W.; Smolka G.; Huczek Z.; Tomassini F.; Cortese B.; Capodanno D.; Chieffo A.; Nunez-Gil I.; Gili S.; Bassignana A.; di Mario C.; Doronzo B.; Omede P.; D'Amico M.; Tedeschi D.; Varbella F.; Luscher T.; Sheiban I.; Escaned J.; Rinaldi M.; D'Ascenzo F. | |
| Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. | 2009 | C. Tamburino;M. E. Di Salvo;D. Capodanno;T. Palmerini;I. Sheiban;M. Margheri;G. Vecchi;G. Sangiorgi;G. Piovaccari;A. Bartorelli;C. Briguori;D. Ardissino;F. D. Pede;A. Ramondo;L. Inglese;A. S. Petronio;L. Bolognese;A. Benassi;C. Palmieri;V. Filippone;S. D. Servi |